Giacomo Koch, MD

Scientific cofounder of Sinaptica.

Articles by Giacomo Koch, MD

The Promise of Personalized Neurostimulation in Slowing Alzheimer Progression: Giacomo Koch, MD, PhD; Ken Mariash; Emiliano Santarnecchi, PhD

ByGiacomo Koch, MD,Ken Mariash,Emiliano Santarnecchi, PhD,Isabella Ciccone, MPH

November 6th 2024

A trio of experts from Sinaptica Therapeutics talked about recent findings presented at CTAD 2024 from a study assessing personalized transcranial magnetic stimulation in patients with Alzheimer disease. [WATCH TIME: 5 minutes]

Giacomo Koch, MD

Articles by Giacomo Koch, MD

The Promise of Personalized Neurostimulation in Slowing Alzheimer Progression: Giacomo Koch, MD, PhD; Ken Mariash; Emiliano Santarnecchi, PhD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Early Results Show Symptom Gains in First Patient Dosed With UX-DA001 Cell Therapy for Parkinson Disease

Testing D1 Receptor Modulator Glovadalen in Phase 2 Trial for Parkinson Disease: Milton Biagioni MD, CMD

Mechanistic Rationale Behind Amlenetug to Treat Multiple System Atrophy: Johan Luthman, PhD

This Week on NeurologyLive® — October 20, 2025

RWJBarnabas and Rutgers Health Researchers Pursue Advanced Neurostimulation Technology to Treat Epileptic Seizures